Trial · NCT05265312
Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care
NCT05265312, Not applicable, Completed, Johns Hopkins University; results first posted 2024-06-25
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care. Trials, record NCT05265312. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05265312
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care
- NCT number
- NCT05265312
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,910 participants, actual
- Lead sponsor
- Johns Hopkins University
- Conditions
- PreDiabetes, Prediabetic State
- Interventions
- START diabetes prevention clinical pathway
- First posted
- 2022-03-03
- Last updated
- 2025-02-05
- Results first posted
- 2024-06-25
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of PCP Visits Where Ppt Was Referred to Diabetes Prevention Program Within 30 Days of Visit | 12 months | Number of PCP visits where ppt referred to Diabetes Prevention Program during intervention period |
| Primary | Number of PCP Visits Where Ppt Was Prescribed Metformin Within 30 Days | 12 months | |
| Primary | Number of PCP Visits Where Ppt Was Referred to Medical Nutrition Therapy Within 30 Days | 12 months | |
| Secondary | Number of Participants Who Complete Glycemic Lab Testing Out of Those With an Order During Intervention Period | 12 months | Fasting glucose or Hemoglobin A1c |
| Secondary | Achieve 5% or Greater Reduction in Weight Compared to Baseline | Baseline and 12 months | Proportion achieving 5% or greater weight reduction |
Source ClinicalTrials.gov
Outcomes5
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of PCP Visits Where Ppt Was Referred to Diabetes Prevention Program Within 30 Days of Visit | 12 months | pcp visits | NUMBER | |
| PRIMARY | Number of PCP Visits Where Ppt Was Prescribed Metformin Within 30 Days | 12 months | pcp visits | NUMBER | |
| PRIMARY | Number of PCP Visits Where Ppt Was Referred to Medical Nutrition Therapy Within 30 Days | 12 months | pcp visits | NUMBER | |
| SECONDARY | Number of Participants Who Complete Glycemic Lab Testing Out of Those With an Order During Intervention Period | 12 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Achieve 5% or Greater Reduction in Weight Compared to Baseline | Baseline and 12 months | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group10
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of PCP Visits Where Ppt Was Referred to Diabetes Prevention Program Within 30 Days of Visit | Intervention Clinic | 47 | pcp visits | ||
| Number of PCP Visits Where Ppt Was Referred to Diabetes Prevention Program Within 30 Days of Visit | Control Clinic | 10 | pcp visits | ||
| Number of PCP Visits Where Ppt Was Prescribed Metformin Within 30 Days | Intervention Clinic | 58 | pcp visits | ||
| Number of PCP Visits Where Ppt Was Prescribed Metformin Within 30 Days | Control Clinic | 39 | pcp visits | ||
| Number of PCP Visits Where Ppt Was Referred to Medical Nutrition Therapy Within 30 Days | Intervention Clinic | 3 | pcp visits | ||
| Number of PCP Visits Where Ppt Was Referred to Medical Nutrition Therapy Within 30 Days | Control Clinic | 37 | pcp visits | ||
| Number of Participants Who Complete Glycemic Lab Testing Out of Those With an Order During Intervention Period | Intervention Clinic | 800 | Participants | ||
| Number of Participants Who Complete Glycemic Lab Testing Out of Those With an Order During Intervention Period | Control Clinic | 906 | Participants | ||
| Achieve 5% or Greater Reduction in Weight Compared to Baseline | Intervention Clinic | 49 | Participants | ||
| Achieve 5% or Greater Reduction in Weight Compared to Baseline | Control Clinic | 43 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Intervention Clinic | 873 | |
| Overall Study | STARTED | Control Clinic | 1,037 | |
| Overall Study | COMPLETED | Intervention Clinic | 873 | |
| Overall Study | COMPLETED | Control Clinic | 1,037 | |
| Overall Study | NOT COMPLETED | Intervention Clinic | 0 | |
| Overall Study | NOT COMPLETED | Control Clinic | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Intervention Clinic | 0 | 0 |
| Total, all-cause mortality | Control Clinic | 0 | 0 |
| Total, other adverse events | Intervention Clinic | 0 | 0 |
| Total, other adverse events | Control Clinic | 0 | 0 |
| Total, serious adverse events | Intervention Clinic | 0 | 0 |
| Total, serious adverse events | Control Clinic | 0 | 0 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| K23DK118205 | Design and Implementation of An Intervention to Improve Prediabetes Management in Primary Care | TSENG, EVA | JOHNS HOPKINS UNIVERSITY | NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES | 2019 to 2023 |
Source NIH RePORTER
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Intervention Clinic vs Control Clinic: Number of Participants Who Complete Glycemic Lab Testing Out of Those With an Order During Intervention Period | Trial comparisons |
| Intervention Clinic vs Control Clinic: Achieve 5% or Greater Reduction in Weight Compared to Baseline | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05265312
GET https://conductscience.org/api/trials/v1/NCT05265312/registered